NewAsk Claude or ChatGPT about AI tools, and they can check Orca.Add Orca to your AI assistant
ToolsCompaniesAbout
Company

Insilico Medicine

Insilico Medicine is a generative AI-driven biotechnology company that develops its Pharma.AI platform for drug discovery and development across biology, chemistry, and clinical development. Its platform supports a self-generated pipeline of drug candidates across oncology, fibrosis, inflammatory, metabolic, and other indications, and it offers software and licensing to pharmaceutical partners. The company also develops Longevity AI models and Environmental Sustainability technologies.

Status
Active
Checked 29 Oct 2026
Based in
Cambridge, Massachusetts, United States
Source ↗
Founded
2014
Source ↗
Tools listed
5

Tools from Insilico Medicine

  • Chemistry42

    Generative AI and physics-based small molecule drug discovery platform

    Apps
    • Web ↗ · Access on request

      Requires a Chemistry42 account or subscription. Plans and access options are on the official product page.

    Verified options shown; other ways to use this tool are still being checked.

    Data · Sign up · Checked

    Subscription options listed; amounts not confirmedMonthly and Yearly (16% off) subscription options and an academia/startup route are listed; verify current prices with the vendor.
  • inClinico

    Clinical trial probability-of-success forecasting and protocol design analysis

    Apps
    • Web ↗ · Access on request

      Existing customers sign in at inclinico.com. New users need to request a demo first, and no self-serve signup was found.

    Verified options shown; other ways to use this tool are still being checked.

    Healthcare · Book a demo · Checked

    Pricing not confirmedContact the vendor via Request a Demo to confirm pricing and plans.
  • Science42: DORA

    AI assistant for drafting academic papers, literature reviews, and related scientific documents

    Apps
    • Web ↗

      Create an account at the sign-up page or log in. The page also mentions subscription plans.

    Verified options shown; other ways to use this tool are still being checked.

    Productivity · Sign up · Checked

    Trial, Advanced, and Professional plansTrial is free for 7 days; Advanced is listed as $35 monthly / $350 annually; Professional is $500 annually.
  • PandaOmics

    AI platform for target identification and disease-gene analysis

    Apps
    • Web ↗

      Create an account or log in. Users are vetted because the platform accepts sensitive data. Academic users can apply for free access, and the page also advertises $199 per month for academia. Enterprise users can contact Insilico. The China version at pandaomics.cn has limited functionality.

    Verified options shown; other ways to use this tool are still being checked.

    Data · Sign up · Checked

    $199 per month for academiaAcademic price listed on the PandaOmics page; other tiers are not specified.
  • Insilico Generative Biologics

    AI platform for designing and optimizing peptides, nanobodies and antibodies

    Platform details not yet confirmed.

    Contact sales ↗

    Use the Contact us or Schedule a Call options, or the request form on the page, and choose Generative Biologics as the product of interest.

    Data · Contact sales · Checked

    Not publishedPricing is arranged through the company; contact sales to confirm terms.

@InSilicoMeds on X

We read everything Insilico Medicine posts on X and summarize what’s worth your time: launches, new features and price changes. The noise stays out.

Insilico Medicine@InSilicoMedsLaunchOct 28View on X ↗

inClinico Agent automates clinical trial landscape analysis

“#inClinico Agent: The Next Generation of Clinical Trial Intelligence inClinico Agent is an advanced AI agent built to automate and accelerate clinical trial intelligence. By translating natural language queries into structured analytical workflows, inClinico Agent compresses months of manual trial landscape analysis into minutes. Read our latest blog here: insilico.com/blog/inclinico…”
Insilico Medicine@InSilicoMedsLaunchOct 27View on X ↗

DDDBench Core: 59 drug discovery benchmarks across five domains

“📊 Introducing DDDBench Core: 59 essential drug discovery benchmarks across five R&D domains, selected from over 300 benchmarks in Foundations. 🔹Generalist Models: See how leading frontier models perform across core drug discovery tasks. GPT-6 Astra currently tops the leaderboard. 🔹Specialist Models: Our compact 2.6B and 4B MMAI Gym models outperform dedicated tools and generalist models on specific tasks, including single-step retrosynthesis, ADMET, Kinome, and GPCR predictions. 🏆 Which models lead in AI-driven drug discovery? Explore the live benchmarks and leaderboards: 👉 dddbench.insilico.com #DDDBench #insilicoSOTAFM”
Insilico Medicine@InSilicoMedsLaunchOct 26View on X ↗

inClinico Agent predicts clinical trial outcomes

“Insilico Medicine introduces #inClinico Agent: An agentic AI system designed to accelerate clinical trial intelligence and predict trial outcomes Read the latest release here: insilico.com/news/pr0f93d4d…”

Pages we check

We re-check these and record what changes